Mission Wealth Management, LP Neurocrine Biosciences Inc Transaction History

Mission Wealth Management, LP

$4.01 Billion
Q1 2025

A detailed history of Mission Wealth Management, LP transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Mission Wealth Management, LP holds 2,210 shares of NBIX stock, worth $271,896. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,210

Previous 1,810 22.1%

Holding current value

$271,896

Previous $247,000 1.21%

% of portfolio

0.01%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 17, 2025	BUY	$107.22 - $153.29 $42,888 - $61,316	400 Added 22.1%	2,210 $244,000
Q4 2024 Feb 06, 2025	BUY	$111.62 - $139.44 $202,032 - $252,386	1,810 New	1,810 $247,000
Q1 2024 Apr 30, 2024	SELL	$130.4 - $143.74 $9,780 - $10,780	-75 Reduced 4.17%	1,725 $237,000
Q4 2023 Feb 05, 2024	SELL	$106.07 - $132.76 $161,756 - $202,459	-1,525 Reduced 45.86%	1,800 $237,000
Q4 2022 Feb 02, 2023	BUY	$106.72 - $127.06 $1,067 - $1,270	10 Added 0.3%	3,325 $397,000
Q1 2021 May 10, 2021	SELL	$87.57 - $119.4 $105,434 - $143,757	-1,204 Reduced 26.64%	3,315 $322,000
Q3 2020 Oct 16, 2020	SELL	$96.16 - $135.15 $115,872 - $162,855	-1,205 Reduced 21.05%	4,519 $435,000
Q2 2020 Aug 03, 2020	BUY	$85.09 - $130.36 $196,472 - $301,001	2,309 Added 67.61%	5,724 $698,000
Q1 2020 Apr 10, 2020	SELL	$75.11 - $113.76 $904,699 - $1.37 Million	-12,045 Reduced 77.91%	3,415 $296,000
Q4 2019 Jan 21, 2020	BUY	$86.8 - $118.57 $441,638 - $603,284	5,088 Added 49.06%	15,460 $1.66 Million
Q3 2019 Oct 16, 2019	SELL	$83.82 - $101.5 $209,549 - $253,750	-2,500 Reduced 19.42%	10,372 $935,000
Q2 2019 Aug 09, 2019	SELL	$72.24 - $91.27 $920,771 - $1.16 Million	-12,746 Reduced 49.75%	12,872 $1.09 Million
Q1 2019 May 14, 2019	BUY	$69.31 - $91.53 $886,059 - $1.17 Million	12,784 Added 99.61%	25,618 $2.26 Million
Q4 2018 Feb 08, 2019	BUY	$68.32 - $124.36 $876,818 - $1.6 Million	12,834 New	12,834 $916,000
Q2 2018 Aug 08, 2018	SELL	$75.3 - $105.99 $197,662 - $278,223	-2,625 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$58.53 - $77.59 $153,641 - $203,673	2,625	2,625 $204,000

Others Institutions Holding NBIX

# of Institutions

650

Shares Held

97.2M

Call Options Held

749K

Put Options Held

553K

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $11.8B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mission Wealth Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Mission Wealth Management, LP with notifications on news.

Account

Mission Wealth Management, LP Neurocrine Biosciences Inc Transaction History